HERNEXEOS vs TECENTRIQ

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. HERNEXEOS and TECENTRIQ are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	HERNEXEOS	TECENTRIQ
Rating	72/100	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	ZONGERTINIB	ATEZOLIZUMAB
Manufacturer	Boehringer Ingelheim	Genentech Inc
Dosage forms	Tablet	Injectable
Drug class	—	—
Boxed warning	None	None
Treats	Non-Small-Cell Lung Carcinoma	Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

hernexeos tecentriq

Rating

72/100

Pharmacy pays

—

Type

Active ingredient

ZONGERTINIB

ATEZOLIZUMAB

Manufacturer

Boehringer Ingelheim

Genentech Inc

Dosage forms

Tablet

Injectable

Drug class

—

Boxed warning

None

Treats

Non-Small-Cell Lung Carcinoma

Urinary Bladder Neoplasms, Non-Small-Cell Lung Carcinoma, Hepatocellular Carcinoma

Frequently asked questions

Which is better-rated, Hernexeos or Tecentriq?

Hernexeos and Tecentriq are tied at 3.6 out of 5 by our independent rating.

What is the difference between Hernexeos and Tecentriq?

Hernexeos contains Zongertinib, while Tecentriq contains Atezolizumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.